{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:30:39Z","timestamp":1793496639053,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270603"],"award-info":[{"award-number":["82270603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470625"],"award-info":[{"award-number":["82470625"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.clinre.2026.102938","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:17:10Z","timestamp":1791847030000},"page":"102938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune-mediated liver injury induced by PD-1\/PD-L1 inhibitors differs from idiosyncratic drug-induced liver injury"],"prefix":"10.1016","volume":"50","author":[{"given":"Yu","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jidong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2975-4176","authenticated-orcid":false,"given":"Xinyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.clinre.2026.102938_bib0001","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3390\/diagnostics15131588","article-title":"Drug-induced autoimmune Hepatitis: robust causality assessment using two different validated and scoring diagnostic algorithms","volume":"15","author":"Teschke","year":"2025","journal-title":"Diagnostics (Basel)"},{"issue":"11\u201312","key":"10.1016\/j.clinre.2026.102938_bib0002","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/apt.18276","article-title":"Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAM","volume":"60","author":"Hountondji","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.clinre.2026.102938_bib0004","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12072-023-10633-7","article-title":"Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update","volume":"18","author":"Mao","year":"2024","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.clinre.2026.102938_bib0005","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00330-022-09041-6","article-title":"Identification of MRI features associated with injury type, severity, and prognosis in drug-induced liver injury","volume":"33","author":"Wu","year":"2023","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.clinre.2026.102938_bib0006","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.clinre.2026.102938_bib0007","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/jgh.15041","article-title":"Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan","volume":"35","author":"Kitagataya","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2026.102938_bib0008","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.clinthera.2023.01.001","article-title":"Hepatotoxicity associated with immune checkpoint inhibitors in clinical practice: a study leveraging data from the US Food and Drug Administration's Adverse Event Reporting System","volume":"45","author":"Wang","year":"2023","journal-title":"Clin Ther"},{"issue":"6","key":"10.1016\/j.clinre.2026.102938_bib0009","article-title":"Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort","volume":"5","author":"Hountondji","year":"2023","journal-title":"JHEP Rep"},{"issue":"5","key":"10.1016\/j.clinre.2026.102938_bib0010","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s00432-022-04340-3","article-title":"Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival","volume":"149","author":"Miah","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"10.1016\/j.clinre.2026.102938_bib0011","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","article-title":"Incidence and etiology of drug-induced liver injury in mainland China","volume":"156","author":"Shen","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinre.2026.102938_bib0012","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cgh.2024.06.030","article-title":"Drug-induced liver injury in Latin America: 10-year experience of the Latin American DILI (LATINDILI) network","volume":"23","author":"Bessone","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2026.102938_bib0013","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s12072-022-10405-9","article-title":"Comparison of the prognostic models for mortality in idiosyncratic drug-induced liver injury","volume":"17","author":"Wang","year":"2023","journal-title":"Hepatol Int"},{"issue":"7","key":"10.1016\/j.clinre.2026.102938_bib0014","first-page":"662","article-title":"Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma","volume":"14","author":"Kahler","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"issue":"9","key":"10.1016\/j.clinre.2026.102938_bib0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.clinre.2026.102938_bib0016","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1007\/s10637-021-01136-z","article-title":"Comparison of clinical features between immune-related sclerosing cholangitis and hepatitis","volume":"39","author":"Takinami","year":"2021","journal-title":"Invest New Drugs"},{"issue":"12","key":"10.1016\/j.clinre.2026.102938_bib0017","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2169\/internalmedicine.9851-17","article-title":"Nivolumab induces sustained liver injury in a patient with malignant melanoma","volume":"57","author":"Matsubara","year":"2018","journal-title":"Intern Med"},{"issue":"9","key":"10.1016\/j.clinre.2026.102938_bib0018","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cgh.2017.12.051","article-title":"Herbal and dietary supplement-induced liver injuries in the Spanish DILI registry","volume":"16","author":"Medina-Caliz","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2026.102938_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/6391712","article-title":"Clinical features of liver injury induced by immune checkpoint inhibitors in Japanese patients","volume":"2019","author":"Imoto","year":"2019","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.clinre.2026.102938_bib0020","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bj\u00f6rnsson","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.clinre.2026.102938_bib0021","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.clinre.2026.102938_bib0022","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12072-019-09940-9","article-title":"A proposed pathologic sub-classification of drug-induced liver injury","volume":"13","author":"Wang","year":"2019","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.clinre.2026.102938_bib0023","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2018.01.033","article-title":"Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors","volume":"68","author":"De Martin","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.clinre.2026.102938_bib0024","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/17425255.2024.2434642","article-title":"Immune-mediated liver injury caused by immune checkpoint inhibitors exhibits distinct clinical features that differ from autoimmune hepatitis","volume":"21","author":"Wang","year":"2025","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"10.1016\/j.clinre.2026.102938_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-014178","article-title":"Circulating exhausted CD8+ effector memory cells differentiate immune checkpoint inhibitor-induced liver injury from other acute immune-mediated liver injuries","volume":"14","author":"Astbury","year":"2026","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.clinre.2026.102938_bib0026","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-017-0300-z","article-title":"Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group","volume":"5","author":"Puzanov","year":"2017","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.clinre.2026.102938_bib0027","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/cancers16040795","article-title":"The ABC of immune-mediated Hepatitis during immunotherapy in patients with cancer: from pathogenesis to multidisciplinary management","volume":"16","author":"Lasagna","year":"2024","journal-title":"Cancers (Basel)"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221074012600183X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221074012600183X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:23:12Z","timestamp":1793496192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221074012600183X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S221074012600183X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102938","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-mediated liver injury induced by PD-1\/PD-L1 inhibitors differs from idiosyncratic drug-induced liver injury","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102938"}}